Sandesh Mahatme

Treasurer, Stalar 3 Inc.

Companies

Vor Biopharma Inc.Chief financial officer Jul 10, 2025 to now¹
CRISPR TherapeuticsBoard member May 30, 2024 to now²
Aeglea BioTherapeuticsBoard member Apr 6, 2016 to Jun 9, 2022³
Sarepta TherapeuticsChief financial officer Nov 7, 2012 to Jul 9, 2020⁴
Flexion TherapeuticsBoard member Jul 24, 2014 to Jun 12, 2020⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Vor Biopharma Inc. VOR0 shares⁶Dec 5, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 5, 2025Returned to company 694,137 shares of Vor Biopharma Inc.⁶
Jul 9, 2025Granted 13,882,750 shares of Vor Biopharma Inc.⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARVor Biopharma Inc., Chief financial officer
2
SEC EDGARCRISPR Therapeutics, Board member
3
SEC EDGARAeglea BioTherapeutics, Board member
4
SEC EDGARSarepta Therapeutics, Chief financial officer
5
SEC EDGARFlexion Therapeutics, Board member
6
SEC EDGARVor Biopharma Inc. shares after the filing of Dec 5, 2025
7
SEC EDGARForm 4 filed Jul 10, 2025